Showing results (1291-1300 of 1,462) with videos related to
Sort By:
Pageof 147
JCI Insight|September 20, 2019
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNKAmber J Giles, Shuyu Hao, Michelle Padget, et al.Genome Research|September 15, 2004
Organization and evolution of a gene-rich region of the mouse genome: a 12.7-Mb region deleted in the Del(13)Svea36H mouseAnn-Marie Mallon, Laurens Wilming, Joseph Weekes, et al.Neuroscience Letters|April 13, 2017
Targeted sequencing of ABCA7 identifies splicing, stop-gain and intronic risk variants for Alzheimer diseaseB W Kunkle, R M Carney, M A Kohli, et al.Oncotarget|June 18, 2020
Efficacy of osimertinib against EGFRvIII+ glioblastomaGustavo Chagoya, Shawn G Kwatra, Cory W Nanni, et al.Genomics|November 24, 1999
Genetic studies of autistic disorder and chromosome 7A Ashley-Koch, C M Wolpert, M M Menold, et al.Human Molecular Genetics|August 25, 2000
Myotilin is mutated in limb girdle muscular dystrophy 1AM A Hauser, S K Horrigan, P Salmikangas, et al.Neuro-Oncology|August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.Journal of Neuro-Oncology|June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningiomaAndrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.Acta Neuropathologica|February 1, 2022
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13Drew Pratt, Zied Abdullaev, Antonios Papanicolau-Sengos, et al.Neuro-Oncology|February 12, 2011
Clinical trial end points for high-grade glioma: the evolving landscapeDavid A Reardon, Evanthia Galanis, John F DeGroot, et al.Pageof 147